Samsung Medical Center
Osteosarcoma treatment cost in the Republic of Korea typically includes a complex diagnosis of sarcoma ranging from $1,900 to $3,400 and primary treatment like Gamma Knife, which runs from $13,500 to $19,200. Total expenses depend on the tumor stage, surgical complexity, and required chemotherapy cycles. Patients generally save 30-50% compared to the US. Top treatment centers are primarily located in Seoul and Incheon.
Typical Osteosarcoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: Patients seeking high-precision surgical outcomes should consider robotic-assisted oncology centers. Korea University Anam Hospital utilizes advanced robotic systems to minimize scarring and blood loss. For complex cases needing integrated digital monitoring, Seoul National University Bundang Hospital (SNUBH) uses the BESTcare system to enhance safety. JCI-accredited facilities like Severance Hospital offer multidisciplinary expertise for international patients at competitive rates.
| Republic of Korea | Turkey | Austria | |
| Gamma Knife | from $13,500 | from $6,300 | from $32,000 |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
| Radiation Therapy for Sarcomas | - | from $3,250 | from $18,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Osteosarcoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Osteosarcoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Osteosarcoma treatment journey.
The doctor is the Head of the Oncology Department, specializing in chemotherapy for lung cancer, head and neck cancer, and esophageal cancer. The focus is on utilizing new clinical drugs to improve treatment outcomes. With extensive experience in oncological therapies, the doctor is at the forefront of cancer treatment advancements.
Dr. Chul-Won Ha is an orthopedic and joint replacement surgeon at Samsung Medical Center in Seoul. He specializes in knee and hip injuries, bone tumors, and complex fractures. Dr. Ha earned both his M.D. and Ph.D. from Seoul National University. He performs procedures at a clinic ranked as a World’s Best Smart Hospital by Newsweek.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
Top South Korean hospitals for osteosarcoma include Asan Medical Center, Severance Hospital, and Samsung Medical Center. These centers provide JCI-accredited care. They offer multidisciplinary treatment involving orthopedic oncology, heavy ion therapy, and limb-sparing surgery. Most facilitate complex reconstructions in specialized sarcoma units.
Bookimed Expert Insight: While many global patients search for general oncology, South Korea's strength lies in high-volume tertiary centers. Samsung Medical Center and Asan Medical Center together treat over 2,000,000 patients annually. This massive scale ensures surgeons maintain high proficiency in rare cases like bone sarcoma. We recommend choosing Seoul-based university hospitals because they integrate pathology and limb reconstruction in one location.
Patient Consensus: Patients emphasize the importance of going directly to a major academic center in Seoul. They notes that having a dedicated orthopedic oncology team for limb-sparing reconstruction is a priority.
Osteosarcoma treatment in Korea primarily uses a multidisciplinary approach combining limb-salvage surgery, neoadjuvant chemotherapy, and advanced radiation. Leading Seoul-based centers specialize in organ-preserving techniques. These facilities utilize Joint Commission International-accredited protocols to maximize joint function and achieve high survival rates for pediatric and adult patients.
Bookimed Expert Insight: Korea's infrastructure for bone cancer is concentrated in massive digitalized hubs. Seoul National University Hospital and Severance Hospital manage over 1,500,000 patients annually. This high volume allows orthopedic oncology teams to specialize in rare procedures like robotic-assisted reconstructions. Patients benefit from this specialized experience which is often unavailable in smaller regional hospitals.
Patient Consensus: Patients prioritize finding surgeons experienced in limb-sparing techniques to ensure the best mobility after recovery. They emphasize the importance of early rehabilitation to regain limb function following long chemotherapy cycles.
In South Korea, patients typically receive a definitive medical diagnosis within 1 to 7 days. Critical tests like CT scans are finalized within 48 hours. Many Seoul-based hospitals provide MRI results on the same day. Comprehensive oncology evaluations for complex cases like osteosarcoma are usually completed within 1 week.
Bookimed Expert Insight: Data shows that tertiary centers in Seoul like Asan Medical Center manage over 11,000 outpatients daily. This massive volume drives efficiency. While general orthopedics might have wait times, choosing a center with a dedicated orthopedic oncology department can significantly compress the diagnostic timeline. These institutions use integrated digital systems to share pathology and imaging results between departments instantly.
Patient Consensus: Patients note that diagnosis speeds up once cancer is suspected. It is vital to bring all previous scans to avoid repeating basic imaging steps.
South Korea hosts highly specialized orthopedic oncologists at JCI-accredited centers in Seoul. Experts like Dr. Myung-Chul Lee at Seoul National University Hospital (SNUH) lead multidisciplinary teams. These specialists focus on bone cancer, providing advanced limb-salvage surgeries and complex reconstructions for international patients.
Bookimed Expert Insight: Patient volume is a reliable proxy for expertise in Korea. Hospitals like Severance serve 1.6 million outpatients annually. This massive scale allows surgeons to specialize intensely in rare conditions like osteosarcoma. Choosing these high-volume facilities ensures access to specialists who focus exclusively on bone tumors.
Patient Consensus: Patients emphasize the need to seek orthopedic oncologists rather than general orthopedists. They note that biopsy technique in Seoul centers significantly affects long-term surgical outcomes.
South Korean oncology centers utilize high-resolution imaging to stage osteosarcoma and plan limb-sparing surgeries. Diagnostic protocols typically include MRI for local tumor assessment and chest CT to monitor for lung metastasis. Hybrid PET/CT and scintigraphy identify distant skeletal lesions within JCI-accredited facilities.
Bookimed Expert Insight: Major Korean hospitals like Asan Medical Center and Samsung Medical Center maintain massive surgical volumes, performing over 45,000 to 65,000 operations annually. This high throughput allows for highly protocol-driven imaging workflows where results are integrated into digital systems like the BESTcare system at SNUBH for immediate surgical planning.
Patient Consensus: Patients note that major hospitals move very quickly with imaging once symptoms appear. Many emphasize keeping digital copies of all scans to facilitate smoother second opinions during their treatment journey.
South Korean hospitals treat osteosarcoma using a multidisciplinary approach combining limb-sparing surgery, intensive chemotherapy, and radiation. Centres like Severance Hospital and Samsung Medical Center often achieve 70% to 80% survival rates. This is due to their combined protocols. Specialists integrate digital imaging for precise tumour removal while preserving limb function.
Bookimed Expert Insight: South Korea's oncology landscape is unique because major centres like Samsung Medical Center operate as digital hubs. They use integrated systems to share real-time MRI and CT imagery across surgical teams. This speed lets clinics like Korea University Anam Hospital offer same-day consultations. They also provide same-day diagnostic tests for new cancer cases. For patients with aggressive bone tumours, this rapid turnaround is a critical advantage. It is the time between arrival and starting chemotherapy.
Patient Consensus: Patients in Republic of Korea emphasise bringing all original pathology slides and scans. They do this for local lab verification before treatment. They note that chemotherapy typically lasts 4 to 6 months. Doctors also openly support seeking second opinions.
South Korean oncology centres report a 5-year survival rate of approximately 73.6% for Stage IIB osteosarcoma. Localised disease survival often exceeds 70%. Paediatric event-free survival sits near 64.6%. These outcomes reflect sophisticated protocols at JCI-accredited facilities like Severance Hospital and Samsung Medical Center.
Bookimed Expert Insight: South Korea's survival rates are bolstered by a high concentration of Newsweek-ranked hospitals in Seoul. While many countries offer standard care, centres like Korea University Anam Hospital provide same-day consultations and tests for new cancer patients. This speed is critical. Patient research shows that starting treatment early correlates more with survival than population-level statistics do.
Patient Consensus: Patients emphasise that metastasis to the lungs is the most critical survival factor. They recommend choosing major university centres. At these centres in South Korea, specialist teams can perform limb-sparing surgery and start chemotherapy within days of diagnosis.
Limb-sparing surgery is not always possible for osteosarcoma in South Korea, although specialists achieve it in 85–95% of cases. Surgeons at centres like Severance Hospital prioritise removing the complete tumour with clear margins. Amputation remains necessary if cancer involves major nerves, blood vessels, or extensive tissue invasion.
Bookimed Expert Insight: While South Korea is known for technical precision, the real advantage for Australian patients is the multidisciplinary approach at major hubs like Samsung Medical Center. Their 17 disease-specific departments coordinate instantly on margin safety. This high-volume environment often allows specialists to accept complex cases that smaller hospitals might deem unsuitable for limb-sparing surgery.
Patient Consensus: Patients highlight that while limb-sparing is the goal, some choose amputation later to restore better function when salvage leads to ongoing pain. They emphasise getting a second opinion at major South Korean university hospitals before finalising a surgical plan.
Leading South Korean hospitals for osteosarcoma treatment include Samsung Medical Center, Severance Hospital, and Asan Medical Center. These Seoul-based facilities offer specialised orthopaedic oncology departments, JCI-accredited safety standards, and modern limb-sparing surgical technologies. They provide multidisciplinary care using Tomotherapy, proton beam therapy, and robotic systems.
Bookimed Expert Insight: While most Australian patients focus on surgical reputation, the real difference in Seoul is the speed of intake. Korea University Anam Hospital offers same-day consultation, testing, and admission for new oncology patients. This rapid staging is critical for osteosarcoma. Starting chemotherapy or surgery quickly can greatly improve the chance of limb preservation.
Patient Consensus: Patients note that major Seoul university hospitals, such as Asan and Severance, are renowned for handling complex cancer cases. They recommend choosing a centre based on appointment speed and the presence of dedicated international clinics with English-speaking support.
Specialists in South Korea manage inoperable osteosarcoma using intensive drug therapies and radiation to control tumour growth. Major Seoul centres use proton beam therapy and Tomotherapy to target tumours near the spine or pelvis. These methods aim to shrink the cancer enough for future surgery.
Bookimed Expert Insight: While high-dose chemotherapy is standard, the availability of specific radiation hardware varies between top-tier Seoul clinics. Samsung Medical Center operates Asia's largest cancer centre with proton beam technology. Conversely, Gangnam Severance Hospital specialises in Tomotherapy for spine-based cases. The tumour's exact location—such as the head or spine—should guide the choice of clinic. This ensures access to the most effective targeted equipment.
Patient Consensus: Patients in South Korea note that doctors often start with chemotherapy to shrink tumours. After that, doctors re-evaluate for surgery. Many recommend getting second opinions at major Seoul hospitals. This can reveal eligibility for clinical trials or immunotherapy when standard options are limited.